The RAs would move faster if someone they loved was dying or just diagnosed gbm. The lack of a buyout right now is ridiculous after seeing the junk companies that have been bought in phase 2 or even slightly advanced with no where near the high quality of results to date.
These differences are unfortunately lost to laymen, which means all of the investment community, other than a few, some of whom are swing traders who short one minute and then buy and take advantage of such ignorance to pad their returns.
I do hope that the scientists will do a better job in their article and lectures even though I know they often think it a sin to speak effusively of scientific results.